Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. Only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure.
Human Antibody Therapeutics For Viral Disease
Scott K. Dessain
Springer Science & Business Media
2007
190 páginas
6h 20m
ISBN-13: 9783540721468
Inglês
Estatísticas
Avaliações
0 / 0- 5 estrelas0%
- 4 estrelas0%
- 3 estrelas0%
- 2 estrelas0%
- 1 estrelas0%